dr. hamilton on fda approval of adjuvant pertuzumab regimen in her2 early breast cancer
Published 6 years ago • 151 plays • Length 0:43Download video MP4
Download video MP3
Similar videos
-
1:10
dr. hamilton on the fda approval of tucatinib in her2 breast cancer
-
1:10
dr. valdes-albini on the fda approval of adjuvant pertuzumab in her2 breast cancer
-
1:53
dr. hamilton on adjuvant therapy for her2 breast cancer
-
1:01
dr. hamilton discusses challenges with approved treatments for her2-positive breast cancer
-
0:51
dr. hamilton on extended adjuvant therapy for her2 breast cancer
-
1:13
dr. pegram discusses adjuvant pertuzumab in her2 breast cancer
-
1:43
dr hamilton on implications of destiny-breast06 on the her2-low breast cancer paradigm
-
11:13
fda approval in her2 early breast cancer, fast track designation in tnbc, and more
-
1:05
dr. hamilton on the optimal duration of trastuzumab in her2 breast cancer
-
1:29
dr. hamilton on the results of the katherine trial in her2 breast cancer
-
20:25
her2 early-stage breast cancer: peri-operative therapy
-
1:14
dr. hamilton on how neratinib targets her2 breast cancer
-
0:47
dr. yee on neoadjuvant pertuzumab in her2-positive breast cancer
-
0:56
dr. hamilton on recent advances in her2 breast cancer
-
2:02
chemotherapy with adjuvant therapy in breast cancer
-
7:30
aphinity trial in her2 breast cancer
-
1:13
dr. hamilton on the efficacy of trastuzumab deruxtecan in her2-low breast cancer
-
1:05
dr. hamilton on the evolution of treatment in her2 breast cancer
-
1:53
dr. pegram on pertuzumab combination for her2-positive breast cancer